A VISIONaerie™ approach
We discover, develop, and commercialize first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye
NEWSAerie Pharmaceuticals Reports Topline Result from Rhopressa®... Aerie Pharmaceuticals to Announce Second Quarter 2018 Financial... Aerie Pharmaceuticals, Inc. and DSM Biomedical, Inc. Expand...
Sep 19, 4:00 PM ET
52 - WEEK LOW/HIGH